Xiao-Li Xie, Jie Wu, Zhong-Yue Li, and Zhi-Gang He were not cited as co-first authors in the published article. The author information has been corrected to denote that Xiao-Li Xie, Jie Wu, Zhong-Yue Li, and Zhi-Gang contributed equally to the article and share first authorship. Additionally, the Author Contributions section has been revised to reflect this amendment. The revised Author Contributions statement appears below.
Statements
Author contributions
The study conception and design were performed by YY, X-LX, JW, Z-YL, and Z-GH. All authors contributed to material preparation, data collection and analysis. The first draft of the manuscript was written by YY and all authors commented on previous versions of the manuscript. Writing - review and editing, supervision and project administration were performed by C-DX. All authors read and approved the final manuscript.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
Shenqu Xiaoshi oral liquid, traditional Chinese medicine, functional dyspepsia, domperidone syrup, children
Citation
Yu Y, Xie X-L, Wu J, Li Z-Y, He Z-G, Liang C-J, Jin Z-Q, Wang A-Z, Gu J, Huang Y, Mei H, Shi W, Hu S-Y, Jiang X, Du J, Hu C-J, Gu L, Jiang M-L, Mao Z-Q and Xu C-D (2022) Corrigendum: Efficacy and Safety of Shenqu Xiaoshi Oral Liquid Compared With Domperidone Syrup in Children With Functional Dyspepsia. Front. Pharmacol. 13:920925. doi: 10.3389/fphar.2022.920925
Received
15 April 2022
Accepted
17 May 2022
Published
13 June 2022
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
13 - 2022
Updates
Copyright
© 2022 Yu, Xie, Wu, Li, He, Liang, Jin, Wang, Gu, Huang, Mei, Shi, Hu, Jiang, Du, Hu, Gu, Jiang, Mao and Xu.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Chun-Di Xu, chundixu55@163.com
†These authors have contributed equally to this work and share first authorship
This article was submitted to Gastrointestinal and Hepatic Pharmacology, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.